Cargando…
I. Foreword-With a Review of the Past Experiences of the Yale Poliomyelitis Study Unit with Oral Poliovirus Vaccines
Autor principal: | Paul, John R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1962
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604397/ https://www.ncbi.nlm.nih.gov/pubmed/21434283 |
Ejemplares similares
-
The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023) -
Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016
por: Ahmad, Mohammad, et al.
Publicado: (2021) -
Expected RATE of Vaccine-Associated Paralytic Poliomyelitis: A Simulation Analysis Regarding Transition from the Trivalent to Bivalent Oral Poliovirus Vaccine
por: Yasri, Sora, et al.
Publicado: (2021) -
Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis — Beijing, China, 2014–2016
por: Zhao, Dan, et al.
Publicado: (2017) -
The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001–11: a retrospective analysis
por: O'Reilly, Kathleen M, et al.
Publicado: (2012)